161 related articles for article (PubMed ID: 14975931)
1. Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy.
Cao C; Kang CW; Kim SZ; Kim SH
Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H150-6. PubMed ID: 14975931
[TBL] [Abstract][Full Text] [Related]
2. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
Mukaddam-Daher S; Menaouar A; Gutkowska J
Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
[TBL] [Abstract][Full Text] [Related]
3. Clonidine and ST-91 may activate imidazoline binding sites in the heart to release atrial natriuretic peptide.
Mukaddam-Daher S; Lambert C; Gutkowska J
Hypertension; 1997 Jul; 30(1 Pt 1):83-7. PubMed ID: 9231825
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic peptide is involved in renal actions of moxonidine.
Mukaddam-Daher S; Gutkowska J
Hypertension; 2000 Jun; 35(6):1215-20. PubMed ID: 10856266
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
Bock C; Niederhoffer N; Szabo B
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
[TBL] [Abstract][Full Text] [Related]
6. Presynaptic imidazoline receptors and alpha 2-adrenoceptors in the human heart: discrimination by clonidine and moxonidine.
Likungu J; Molderings GJ; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):689-92. PubMed ID: 8938671
[TBL] [Abstract][Full Text] [Related]
7. Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist.
El-Ayoubi R; Menaouar A; Gutkowska J; Mukaddam-Daher S
Br J Pharmacol; 2005 May; 145(1):50-6. PubMed ID: 15700025
[TBL] [Abstract][Full Text] [Related]
8. Effects of the I(1) imidazoline/alpha(2)-adrenergic receptor agonist moxonidine in comparison with clonidine in the formalin test in rats.
Shannon HE; Lutz EA
Pain; 2000 Mar; 85(1-2):161-7. PubMed ID: 10692615
[TBL] [Abstract][Full Text] [Related]
9. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.
Haxhiu MA; Dreshaj I; Schäfer SG; Ernsberger P
J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S1-8. PubMed ID: 7533221
[TBL] [Abstract][Full Text] [Related]
10. Imidazoline receptors in the heart: a novel target and a novel mechanism of action that involves atrial natriuretic peptides.
Mukaddam-Daher S; Gutkowska J
Braz J Med Biol Res; 2004 Aug; 37(8):1239-45. PubMed ID: 15273826
[TBL] [Abstract][Full Text] [Related]
11. Relative importance of central imidazoline receptors for the antihypertensive effects of moxonidine and rilmenidine.
Chan CK; Head GA
J Hypertens; 1996 Jul; 14(7):855-64. PubMed ID: 8818924
[TBL] [Abstract][Full Text] [Related]
12. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
Szabo B; Urban R
Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
[TBL] [Abstract][Full Text] [Related]
13. Importance of imidazoline-preferring receptors in the cardiovascular actions of chronically administered moxonidine, rilmenidine and clonidine in conscious rabbits.
Parkin ML; Godwin SJ; Head GA
J Hypertens; 2003 Jan; 21(1):167-78. PubMed ID: 12544449
[TBL] [Abstract][Full Text] [Related]
14. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
Molderings GJ; Likungu J; Jakschik J; Göthert M
Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
[TBL] [Abstract][Full Text] [Related]
15. Renal and blood pressure effects of moxonidine and clonidine in spontaneously hypertensive rats.
Hohage H; Hess K; Jahl C; Greven J; Schlatter E
Clin Nephrol; 1997 Dec; 48(6):346-52. PubMed ID: 9438092
[TBL] [Abstract][Full Text] [Related]
16. A search for presynaptic imidazoline receptors at rabbit and rat noradrenergic neurones in the absence of alpha 2-autoinhibition.
Gaiser EG; Trendelenburg AU; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1999 Feb; 359(2):123-32. PubMed ID: 10048597
[TBL] [Abstract][Full Text] [Related]
17. Role of I(1)-imidazoline receptors and alpha2-adrenoceptors in hemodynamic effects of moxonidine administration into the rostroventrolateral medulla.
Khokhlova ON; Murashev AN; Medvedev OS
Bull Exp Biol Med; 2001 Apr; 131(4):336-9. PubMed ID: 11550020
[TBL] [Abstract][Full Text] [Related]
18. Chronic imidazoline receptor activation in spontaneously hypertensive rats.
Menaouar A; El-Ayoubi R; Jankowski M; Gutkowska J; Mukaddam-Daher S
Am J Hypertens; 2002 Sep; 15(9):803-8. PubMed ID: 12219876
[TBL] [Abstract][Full Text] [Related]
19. Effects of moxonidine and clonidine on potassium excretion in Sprague-Dawley rats.
Hohage H; Mehrens T; Matzkies F; Steinmetz M; Greven J
Pharmacol Res; 1999 May; 39(5):357-61. PubMed ID: 10328993
[TBL] [Abstract][Full Text] [Related]
20. alpha(2)-adrenergic receptors are not required for central anti-hypertensive action of moxonidine in mice.
Tolentino-Silva FP; Haxhiu MA; Waldbaum S; Dreshaj IA; Ernsberger P
Brain Res; 2000 Apr; 862(1-2):26-35. PubMed ID: 10799665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]